The Aqueous Diagnostics MD8151E Nano-Check Influenze + COVID-19 Dual Test is a cutting-edge, rapid diagnostic solution designed for use in clinical, laboratory, and point-of-care settings. This innovative test offers a convenient and efficient way to detect and differentiate between Influenza A, Influenza B, and COVID-19, providing healthcare professionals with critical information to inform patient care and treatment decisions.

The MD8151E Nano-Check test is a one-step, lateral flow immunoassay that utilizes a proprietary nano-particle technology to deliver highly sensitive and specific results. This test is intended for the qualitative detection of Influenza A, Influenza B, and COVID-19 antigens in human nasopharyngeal swab specimens, providing a valuable tool for healthcare professionals to diagnose and manage respiratory infections.

Key Features

• Rapid results in 15 minutes or less
• Highly sensitive and specific nano-particle technology
• One-step, easy-to-use test procedure
• Qualitative detection of Influenza A, Influenza B, and COVID-19 antigens
• Convenient and portable design for use in various settings
• 20 tests per kit for high-volume testing needs
• Simple and intuitive test interpretation

Product Specifications

• Dimensions: 5.5 x 3.5 x 2.5 inches (14 x 8.9 x 6.4 cm) • Weight: 1.2 pounds (0.54 kg) • Materials: Plastic, nano-particles, and other proprietary components • Compliance: Meets or exceeds relevant regulatory standards for in vitro diagnostic devices

Ideal For

• Hospitals and emergency departments • Clinical laboratories and reference labs • Outpatient clinics and urgent care centers • Point-of-care settings, such as physician offices and nursing homes • Home care and telehealth applications (with proper training and supervision)